Table 1. Association between high SNAT1 expression and clinicopathological factors in osteosarcoma.
| Clinicopathological factor | N | SNAT1 | χ2 | P | |
|---|---|---|---|---|---|
| Low (%) | High (%) | ||||
| Size | |||||
| >8cm | 101 | 19(18.8) | 83(82.2) | 25.12 | 0.001 |
| ≤8cm | 64 | 36(56.2) | 28(43.8) | ||
| Location | |||||
| Femora | 62 | 17(27.4) | 45(72.6) | 5.02 | NS |
| Tibia | 54 | 24(44.4) | 30(55.5) | ||
| Others | 49 | 13(26.5) | 36(73.4) | ||
| Survival time | |||||
| <3y | 116 | 21(17.9) | 95(82.1) | 37.94 | 0.001 |
| ≥3y | 49 | 33(66.7) | 16(33.3) | ||
| Metastasis status | |||||
| Lung | 99 | 17(16.7) | 82(83.3) | 62.49 | 0.001 |
| Others | 41 | 12(30) | 29(70) | ||
| None | 25 | 25(100) | 0(0) | ||
| Sex | |||||
| Male | 118 | 36(31.2) | 82(68.8) | 0.72 | NS |
| Female | 47 | 18(37.5) | 29(62.5) | ||
| Age, y | |||||
| <18 | 124 | 40(33.3) | 82(66.7) | 0.17 | NS |
| ≥18 | 41 | 12(30) | 29(70) | ||